28
2700:Medicine(比率: 77.4 %)
| DOI | タイトル | 著者 | ジャーナル | 発行年 | 科研費成果論文 |
|---|---|---|---|---|---|
| 10.1001/jamaoncol.2020.4564 | Efficacy And Safety Of Nivolumab Plus Ipilimumab In Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib | Yau, Thomas; Kang, Yoon-Koo; Kim, Tae-You; El-Khoueiry, Anthony B.; Santoro, Armando; Sangro, Bruno; Melero, Ignacio; Kudo, Masatoshi; Hou, Ming-Mo; Matilla, Ana; Tovoli, Francesco; Knox, Jennifer J.; Ruth He, Aiwu; El-Rayes, Bassel F.; Acosta-Rivera, Mirelis; Lim, Ho-Yeong; Neely, Jaclyn; Shen, Yun; Wisniewski, Tami; Anderson, Jeffrey; Hsu, Chiun | Jama Oncology | 2020 | NA |
| 10.1016/j.jhep.2018.04.010 | Outcomes Of Sequential Treatment With Sorafenib Followed By Regorafenib For Hcc: Additional Analyses From The Phase Iii Resorce Trial | Finn, Richard S.; Merle, Philippe; Granito, Alessandro; Huang, Yi-Hsiang; Bodoky, Gyorgy; Pracht, Marc; Yokosuka, Osamu; Rosmorduc, Olivier; Gerolami, Rene; Caparello, Chiara; Cabrera, Roniel; Chang, Charissa; Sun, Weijing; Leberre, Marie-Aude; Baumhauer, Annette; Meinhardt, Gerold; Bruix, Jordi | Journal Of Hepatology | 2018 | NA |
| 10.1016/j.jhep.2019.05.014 | Nivolumab In Advanced Hepatocellular Carcinoma: Sorafenib-Experienced Asian Cohort Analysis | Yau, Thomas; Hsu, Chiun, 0000-0002-1122-0055; Kim, Tae-You; Choo, Su-Pin; Kang, Yoon-Koo; Hou, Ming-Mo; Numata, Kazushi; Yeo, Winnie; Chopra, Akhil; Ikeda, Masafumi; Kuromatsu, Ryoko; Moriguchi, Michihisa; Chao, Yee; Zhao, Huanyu; Anderson, Jeffrey; Cruz, Christine Dela; Kudo, Masatoshi, 0000-0002-4102-3474 | Journal Of Hepatology | 2019 | NA |
| 10.1016/j.jhep.2019.08.006 | Impact Of Combined Selective Internal Radiation Therapy And Sorafenib On Survival In Advanced Hepatocellular Carcinoma | Ricke, Jens; Klumpen, Heinz Josef; Amthauer, Holger; Bargellini, Irene; Bartenstein, Peter; De Toni, Enrico N.; Gasbarrini, Antonio; Pech, Maciej; Peck-Radosavljevic, Markus, 0000-0002-0597-2728; Popovi<U+010D>, Peter; Rosmorduc, Olivier; Schott, Eckart; Seidensticker, Max; Verslype, Chris; Sangro, Bruno; Malfertheiner, Peter | Journal Of Hepatology | 2019 | NA |
| 10.1016/j.jhep.2020.07.026 | Association Of Inflammatory Biomarkers With Clinical Outcomes In Nivolumab-Treated Patients With Advanced Hepatocellular Carcinoma | Sangro, Bruno; Melero, Ignacio; Wadhawan, Samir; Finn, Richard S., 0000-0003-2494-2126; Abou-Alfa, Ghassan K.; Cheng, Ann-Lii; Yau, Thomas; Furuse, Junji, 0000-0003-0663-6117; Park, Joong-Won, 0000-0001-9972-0494; Boyd, Zachary; Tang, Hao (Tracy); Shen, Yun, 0000-0002-2078-1161; Tschaika, Marina; Neely, Jaclyn; El-Khoueiry, Anthony | Journal Of Hepatology | 2020 | NA |
| 10.1016/s0140-6736(18)30207-1 | Lenvatinib Versus Sorafenib In First-Line Treatment Of Patients With Unresectable Hepatocellular Carcinoma: A Randomised Phase 3 Non-Inferiority Trial | Kudo, Masatoshi; Finn, Richard S; Qin, Shukui; Han, Kwang-Hyub; Ikeda, Kenji; Piscaglia, Fabio; Baron, Ari; Park, Joong-Won; Han, Guohong; Jassem, Jacek; Blanc, Jean Frederic; Vogel, Arndt; Komov, Dmitry; Evans, T R Jeffry; Lopez, Carlos; Dutcus, Corina; Guo, Matthew; Saito, Kenichi; Kraljevic, Silvija; Tamai, Toshiyuki; Ren, Min; Cheng, Ann-Lii | The Lancet | 2018 | TRUE |
| 10.1016/s1470-2045(18)30146-3 | Tivantinib For Second-Line Treatment Of Met-High, Advanced Hepatocellular Carcinoma (Metiv-Hcc): A Final Analysis Of A Phase 3, Randomised, Placebo-Controlled Study | Rimassa, Lorenza; Assenat, Eric; Peck-Radosavljevic, Markus; Pracht, Marc; Zagonel, Vittorina; Mathurin, Philippe; Rota Caremoli, Elena; Porta, Camillo; Daniele, Bruno; Bolondi, Luigi; Mazzaferro, Vincenzo; Harris, William; Damjanov, Nevena; Pastorelli, Davide; Reig, Maria; Knox, Jennifer; Negri, Francesca; Trojan, Jorg; Lopez Lopez, Carlos; Personeni, Nicola; Decaens, Thomas; Dupuy, Marie; Sieghart, Wolfgang; Abbadessa, Giovanni; Schwartz, Brian; Lamar, Maria; Goldberg, Terri; Shuster, Dale; Santoro, Armando; Bruix, Jordi | The Lancet Oncology | 2018 | NA |
| 10.1016/s1470-2045(18)30351-6 | Pembrolizumab In Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib (Keynote-224): A Non-Randomised, Open-Label Phase 2 Trial | Zhu, Andrew X; Finn, Richard S; Edeline, Julien; Cattan, Stephane; Ogasawara, Sadahisa; Palmer, Daniel; Verslype, Chris; Zagonel, Vittorina; Fartoux, Laetitia; Vogel, Arndt; Sarker, Debashis; Verset, Gontran; Chan, Stephen L; Knox, Jennifer; Daniele, Bruno; Webber, Andrea L; Ebbinghaus, Scot W; Ma, Junshui; Siegel, Abby B; Cheng, Ann-Lii; Kudo, Masatoshi; Alistar, Angela; Asselah, Jamil; Blanc, Jean-Frederic; Borbath, Ivan; Cannon, Timothy; Chung, Ki; Cohn, Allen; Cosgrove, David P; Damjanov, Nevena; Gupta, Mukul; Karino, Yoshivasu; Karwal, Mark; Kaubisch, Andreas; Kelley, Robin; Van Laethem, Jena-Luc; Larson, Timothy; Lee, James; Li, Daneng; Manhas, Atisha; Manji, Gulam Abbas; Numata, Kazushi; Parsons, Benjamin; Paulson, Andrew S.; Pinto, Carmine; Ramirez, Robert; Ratnam, Suresh; Rizell, Magnus; Rosmorduc, Olivier; Sada, Yvonne; Sasaki, Yutaka; Stal, Per I; Strasser, Simone; Trojan, Joerg; Vaccaro, Gina; Van Vlierberghe, Hans; Weiss, Alan; Weiss, Karl-Heinz; Yamashita, Tatsuya | The Lancet Oncology | 2018 | TRUE |
| 10.1016/s1470-2045(18)30937-9 | Zhu, Andrew X; Kang, Yoon-Koo; Yen, Chia-Jui; Finn, Richard S; Galle, Peter R; Llovet, Josep M; Assenat, Eric; Brandi, Giovanni; Pracht, Marc; Lim, Ho Yeong; Rau, Kun-Ming; Motomura, Kenta; Ohno, Izumi; Merle, Philippe; Daniele, Bruno; Shin, Dong Bok; Gerken, Guido; Borg, Christophe; Hiriart, Jean-Baptiste; Okusaka, Takuji; Morimoto, Manabu; Hsu, Yanzhi; Abada, Paolo B; Kudo, Masatoshi | The Lancet Oncology | 2019 | TRUE | |
| 10.1016/s1470-2045(20)30011-5 | Camrelizumab In Patients With Previously Treated Advanced Hepatocellular Carcinoma: A Multicentre, Open-Label, Parallel-Group, Randomised, Phase 2 Trial | Qin, Shukui; Ren, Zhenggang; Meng, Zhiqiang; Chen, Zhendong; Chai, Xiaoli; Xiong, Jianping; Bai, Yuxian; Yang, Lin; Zhu, Hong; Fang, Weijia; Lin, Xiaoyan; Chen, Xiaoming; Li, Enxiao; Wang, Linna; Chen, Chunxia; Zou, Jianjun | The Lancet Oncology | 2020 | NA |
| 10.1016/s1470-2045(20)30156-x | Atezolizumab With Or Without Bevacizumab In Unresectable Hepatocellular Carcinoma (Go30140): An Open-Label, Multicentre, Phase 1B Study | Lee, Michael S; Ryoo, Baek-Yeol; Hsu, Chih-Hung; Numata, Kazushi; Stein, Stacey; Verret, Wendy; Hack, Stephen P; Spahn, Jessica; Liu, Bo; Abdullah, Heba; Wang, Yulei; He, Aiwu Ruth; Lee, Kyung-Hun; Bang, Y-J; Bendell, J; Chao, Y; Chen, J-S; Chung, H C; Davis, S L; Dev, A; Gane, E; George, B; He, A R; Hochster, H; Hsu, C-H; Ikeda, M; Lee, J; Lee, M; Mahipal, A; Manji, G; Morimoto, M; Numata, K; Pishvaian, M; Qin, S; Ryan, D; Ryoo, B-Y; Sasahira, N; Stein, S; Strickler, J; Tebbutt, N | The Lancet Oncology | 2020 | NA |
| 10.1038/s41572-020-00240-3 | Hepatocellular Carcinoma | Llovet, Josep M., 0000-0003-0547-2667; Kelley, Robin Kate; Villanueva, Augusto, 0000-0003-3585-3727; Singal, Amit G.; Pikarsky, Eli; Roayaie, Sasan; Lencioni, Riccardo; Koike, Kazuhiko; Zucman-Rossi, Jessica, 0000-0002-5687-0334; Finn, Richard S. | Nature Reviews Disease Primers | 2021 | NA |
| 10.1038/s41586-021-03362-0 | Nash Limits Anti-Tumour Surveillance In Immunotherapy-Treated Hcc | Nature | 2021 | NA | |
| 10.1053/j.gastro.2019.01.261 | Biomarkers Associated With Response To Regorafenib In Patients With Hepatocellular Carcinoma | Teufel, Michael; Seidel, Henrik; Kochert, Karl; Meinhardt, Gerold; Finn, Richard S.; Llovet, Josep M.; Bruix, Jordi | Gastroenterology | 2019 | NA |
| 10.1056/nejmoa1717002 | Cabozantinib In Patients With Advanced And Progressing Hepatocellular Carcinoma | Abou-Alfa, Ghassan K.; Meyer, Tim; Cheng, Ann-Lii; El-Khoueiry, Anthony B.; Rimassa, Lorenza; Ryoo, Baek-Yeol; Cicin, Irfan; Merle, Philippe; Chen, Yenhsun; Park, Joong-Won; Blanc, Jean-Frederic; Bolondi, Luigi; Klumpen, Heinz-Josef; Chan, Stephen L.; Zagonel, Vittorina; Pressiani, Tiziana; Ryu, Min-Hee; Venook, Alan P.; Hessel, Colin; Borgman-Hagey, Anne E.; Schwab, Gisela; Kelley, Robin K. | New England Journal Of Medicine | 2018 | NA |
| 10.1056/nejmoa1915745 | Atezolizumab Plus Bevacizumab In Unresectable Hepatocellular Carcinoma | Finn, Richard S.; Qin, Shukui; Ikeda, Masafumi; Galle, Peter R.; Ducreux, Michel; Kim, Tae-You; Kudo, Masatoshi; Breder, Valeriy; Merle, Philippe; Kaseb, Ahmed O.; Li, Daneng; Verret, Wendy; Xu, Derek-Zhen; Hernandez, Sairy; Liu, Juan; Huang, Chen; Mulla, Sohail; Wang, Yulei; Lim, Ho Yeong; Zhu, Andrew X.; Cheng, Ann-Lii | New England Journal Of Medicine | 2020 | NA |
| 10.1093/annonc/mdz394.029 | Checkmate 459: A Randomized, Multi-Center Phase Iii Study Of Nivolumab (Nivo) Vs Sorafenib (Sor) As First-Line (1L) Treatment In Patients (Pts) With Advanced Hepatocellular Carcinoma (Ahcc) | Yau, T.; Park, J.W.; Finn, R.S.; Cheng, A.-L.; Mathurin, P.; Edeline, J.; Kudo, M.; Han, K.-H.; Harding, J.J.; Merle, P.; Rosmorduc, O.; Wyrwicz, L.; Schott, E.; Choo, S.P.; Kelley, R.K.; Begic, D.; Chen, G.; Neely, J.; Anderson, J.; Sangro, B. | Annals Of Oncology | 2019 | NA |
| 10.1093/annonc/mdz446.002 | Imbrave150: Efficacy And Safety Results From A Ph Iii Study Evaluating Atezolizumab (Atezo) + Bevacizumab (Bev) Vs Sorafenib (Sor) As First Treatment (Tx) For Patients (Pts) With Unresectable Hepatocellular Carcinoma (Hcc) | Cheng, A.-L.; Qin, S.; Ikeda, M.; Galle, P.; Ducreux, M.; Zhu, A.; Kim, T.-Y.; Kudo, M.; Breder, V.; Merle, P.; Kaseb, A.; Li, D.; Verret, W.; Xu, Z.; Hernandez, S.; Liu, J.; Huang, C.; Mulla, S.; Lim, H.Y.; Finn, R. | Annals Of Oncology | 2019 | NA |
| 10.1158/1078-0432.ccr-18-2484 | Anti-Pd-1 Antibody Shr-1210 Combined With Apatinib For Advanced Hepatocellular Carcinoma, Gastric, Or Esophagogastric Junction Cancer: An Open-Label, Dose Escalation And Expansion Study | Xu, Jianming; Zhang, Yun; Jia, Ru; Yue, Chunyan; Chang, Lianpeng; Liu, Rongrui; Zhang, Gairong; Zhao, Chuanhua; Zhang, Yaoyue; Chen, Chunxia; Wang, Yan; Yi, Xin; Hu, Zhiyuan, 0000-0003-2212-0268; Zou, Jianjun; Wang, Quanren | Clinical Cancer Research | 2018 | NA |
| 10.1200/jco.19.01307 | Pembrolizumab As Second-Line Therapy In Patients With Advanced Hepatocellular Carcinoma In Keynote-240: A Randomized, Double-Blind, Phase Iii Trial | Finn, Richard S.; Ryoo, Baek-Yeol; Merle, Philippe; Kudo, Masatoshi; Bouattour, Mohamed; Lim, Ho Yeong; Breder, Valeriy; Edeline, Julien; Chao, Yee; Ogasawara, Sadahisa; Yau, Thomas; Garrido, Marcelo; Chan, Stephen L.; Knox, Jennifer; Daniele, Bruno; Ebbinghaus, Scot W.; Chen, Erluo; Siegel, Abby B.; Zhu, Andrew X.; Cheng, Ann-Lii | Journal Of Clinical Oncology | 2020 | NA |
| 10.1200/jco.20.00808 | Phase Ib Study Of Lenvatinib Plus Pembrolizumab In Patients With Unresectable Hepatocellular Carcinoma | Finn, Richard S.; Ikeda, Masafumi; Zhu, Andrew X.; Sung, Max W.; Baron, Ari D.; Kudo, Masatoshi; Okusaka, Takuji; Kobayashi, Masahiro; Kumada, Hiromitsu; Kaneko, Shuichi; Pracht, Marc; Mamontov, Konstantin; Meyer, Tim; Kubota, Tomoki; Dutcus, Corina E.; Saito, Kenichi; Siegel, Abby B.; Dubrovsky, Leonid; Mody, Kalgi; Llovet, Josep M. | Journal Of Clinical Oncology | 2020 | NA |
| 10.1200/jco.2017.76.0892 | Sirvenib: Selective Internal Radiation Therapy Versus Sorafenib In Asia-Pacific Patients With Hepatocellular Carcinoma | Chow, Pierce K.H.; Gandhi, Mihir; Tan, Say-Beng; Khin, Maung Win; Khasbazar, Ariunaa; Ong, Janus; Choo, Su Pin; Cheow, Peng Chung; Chotipanich, Chanisa; Lim, Kieron; Lesmana, Laurentius A.; Manuaba, Tjakra W.; Yoong, Boon Koon; Raj, Aloysius; Law, Chiong Soon; Cua, Ian H.Y.; Lobo, Rolley R.; Teh, Catherine S.C.; Kim, Yun Hwan; Jong, Yun Won; Han, Ho-Seong; Bae, Si-Hyun; Yoon, Hyun-Ki; Lee, Rheun-Chuan; Hung, Chien-Fu; Peng, Cheng-Yuan; Liang, Po-Chin; Bartlett, Adam; Kok, Kenneth Y.Y.; Thng, Choon-Hua; Low, Albert Su-Chong; Goh, Anthony S.W.; Tay, Kiang Hiong; Lo, Richard H.G.; Goh, Brian K.P.; Ng, David C.E.; Lekurwale, Ganesh; Liew, Wei Ming; Gebski, Val; Mak, Kenneth S.W.; Soo, Khee Chee | Journal Of Clinical Oncology | 2018 | NA |
| 10.1200/jco.2019.37.15_suppl.4004 | Results Of Keynote-240: Phase 3 Study Of Pembrolizumab (Pembro) Vs Best Supportive Care (Bsc) For Second Line Therapy In Advanced Hepatocellular Carcinoma (Hcc). | Finn, Richard S.; Ryoo, Baek-Yeol; Merle, Philippe; Kudo, Masatoshi; Bouattour, Mohamed; Lim, Ho-Yeong; Breder, Valeriy Vladimirovich; Edeline, Julien; Chao, Yee; Ogasawara, Sadahisa; Yau, Thomas; Garrido, Marcelo; Chan, Stephen Lam; Knox, Jennifer J.; Daniele, Bruno; Ebbinghaus, Scot; Chen, Erluo; Siegel, Abby B.; Zhu, Andrew X.; Cheng, Ann-Lii | Journal Of Clinical Oncology | 2019 | NA |
| 10.1200/jco.2019.37.15_suppl.4012 | Nivolumab (Nivo) + Ipilimumab (Ipi) Combination Therapy In Patients (Pts) With Advanced Hepatocellular Carcinoma (Ahcc): Results From Checkmate 040. | Yau, Thomas; Kang, Yoon-Koo; Kim, Tae-You; El-Khoueiry, Anthony B.; Santoro, Armando; Sangro, Bruno; Melero, Ignacio; Kudo, Masatoshi; Hou, Ming-Mo; Matilla, Ana; Tovoli, Francesco; Knox, Jennifer J.; He, Aiwu Ruth; El-Rayes, Bassel F.; Acosta-Rivera, Mirelis; Neely, Jaclyn; Shen, Yun; Baccan, Carlos; Dela Cruz, Christine Marie; Hsu, Chiun | Journal Of Clinical Oncology | 2019 | NA |
| 10.1200/jco.2019.37.4_suppl.327 | Checkmate-040: Nivolumab (Nivo) In Patients (Pts) With Advanced Hepatocellular Carcinoma (Ahcc) And Child-Pugh B (Cpb) Status. | Kudo, Masatoshi; Matilla, Ana; Santoro, Armando; Melero, Ignacio; Gracian, Antonio Cubillo; Acosta-Rivera, Mirelis; Choo, Su Pin; El-Khoueiry, Anthony B.; Kuromatsu, Ryoko; El-Rayes, Bassel F.; Numata, Kazushi; Itoh, Yoshito; Di Costanzo, Francesco; Crysler, Oxana V.; Reig, Maria; Shen, Yun; Neely, Jaclyn; Dela Cruz, Christine Marie; Baccan, Carlos; Sangro, Bruno | Journal Of Clinical Oncology | 2019 | NA |
| 10.1200/jco.2020.38.15_suppl.4508 | Efficacy, Tolerability, And Biologic Activity Of A Novel Regimen Of Tremelimumab (T) In Combination With Durvalumab (D) For Patients (Pts) With Advanced Hepatocellular Carcinoma (Ahcc). | Kelley, Robin Kate; Sangro, Bruno; Harris, William Proctor; Ikeda, Masafumi; Okusaka, Takuji; Kang, Yoon-Koo; Qin, Shukui; Tai, Wai Meng David; Lim, Ho Yeong; Yau, Thomas; Yong, Wei-Peng; Cheng, Ann-Lii; Gasbarrini, Antonio; De Braud, Filippo G.; Bruix, Jordi; Borad, Mitesh J.; He, Philip; Negro, Alejandra; Kudo, Masatoshi; Abou-Alfa, Ghassan K. | Journal Of Clinical Oncology | 2020 | NA |
| 10.1200/jco.2020.38.4_suppl.478 | Nivolumab (Nivo) + Ipilimumab (Ipi) + Cabozantinib (Cabo) Combination Therapy In Patients (Pts) With Advanced Hepatocellular Carcinoma (Ahcc): Results From Checkmate 040. | Yau, Thomas; Zagonel, Vittorina; Santoro, Armando; Acosta-Rivera, Mirelis; Choo, Su Pin; Matilla, Ana; He, Aiwu Ruth; Cubillo Gracian, Antonio; El-Khoueiry, Anthony B.; Sangro, Bruno; Eldawy, Tarek; Bruix, Jordi; Frassineti, Giovanni; Vaccaro, Gina M.; Tschaika, Marina; Scheffold, Christian; Shen, Yun; Neely, Jaclyn; Piscaglia, Fabio | Journal Of Clinical Oncology | 2020 | NA |
| 10.1200/jco.2021.39.3_suppl.267 | Imbrave150: Updated Overall Survival (Os) Data From A Global, Randomized, Open-Label Phase Iii Study Of Atezolizumab (Atezo) + Bevacizumab (Bev) Versus Sorafenib (Sor) In Patients (Pts) With Unresectable Hepatocellular Carcinoma (Hcc). | Finn, Richard S.; Qin, Shukui; Ikeda, Masafumi; Galle, Peter R.; Ducreux, Michel; Kim, Tae-You; Lim, Ho Yeong; Kudo, Masatoshi; Breder, Valeriy Vladimirovich; Merle, Philippe; Kaseb, Ahmed Omar; Li, Daneng; Verret, Wendy; Shao, Hui; Liu, Juan; Li, Lindong; Zhu, Andrew X.; Cheng, Ann-Lii | Journal Of Clinical Oncology | 2021 | NA |